These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
254 related articles for article (PubMed ID: 34175686)
1. Circ_0030586 inhibits cell proliferation and stemness in bladder cancer by inactivating the ERK signaling via miR-665/NR4A3 axis. Fan L; Yang J; Shen C; Wu Z; Hu H Acta Histochem; 2021 Jul; 123(5):151745. PubMed ID: 34175686 [TBL] [Abstract][Full Text] [Related]
2. circST6GALNAC6 suppresses bladder cancer metastasis by sponging miR-200a-3p to modulate the STMN1/EMT axis. Tan S; Kang Y; Li H; He HQ; Zheng L; Wu SQ; Ai K; Zhang L; Xu R; Zhang XZ; Zhao XK; Zhu X Cell Death Dis; 2021 Feb; 12(2):168. PubMed ID: 33568625 [TBL] [Abstract][Full Text] [Related]
3. Blocking hsa_circ_0006168 suppresses cell proliferation and motility of human glioblastoma cells by regulating hsa_circ_0006168/miR-628-5p/IGF1R ceRNA axis. Wang T; Mao P; Feng Y; Cui B; Zhang B; Chen C; Xu M; Gao K Cell Cycle; 2021 Jun; 20(12):1181-1194. PubMed ID: 34024251 [TBL] [Abstract][Full Text] [Related]
4. Knockdown of circ_0006528 Suppresses Cell Proliferation, Migration, Invasion, and Adriamycin Chemoresistance via Regulating the miR-1236-3p/CHD4 Axis in Breast Cancer. Hao J; Du X; Lv F; Shi Q J Surg Res; 2021 Apr; 260():104-115. PubMed ID: 33333383 [TBL] [Abstract][Full Text] [Related]
5. CircHGS enhances the progression of bladder cancer by regulating the miR-513a-5p/VEGFC axis and activating the AKT/mTOR signaling pathway. Zhu Y; Zuo L; Xiong H; Li S; Chen R; Liu H Cell Cycle; 2023 Apr; 22(8):919-938. PubMed ID: 36617735 [TBL] [Abstract][Full Text] [Related]
6. Cyclic RNA hsa_circ_0091017 inhibits proliferation, migration and invasiveness of bladder cancer cells by binding to microRNA-589-5p. Zhang L; Xia HB; Zhao CY; Shi L; Ren XL Eur Rev Med Pharmacol Sci; 2020 Jan; 24(1):86-96. PubMed ID: 31957821 [TBL] [Abstract][Full Text] [Related]
7. Circular RNA circ-ZKSCAN1 inhibits bladder cancer progression through miR-1178-3p/p21 axis and acts as a prognostic factor of recurrence. Bi J; Liu H; Dong W; Xie W; He Q; Cai Z; Huang J; Lin T Mol Cancer; 2019 Sep; 18(1):133. PubMed ID: 31481066 [TBL] [Abstract][Full Text] [Related]
8. Hsa_circ_0001944 promotes the growth and metastasis in bladder cancer cells by acting as a competitive endogenous RNA for miR-548. Jin M; Lu S; Wu Y; Yang C; Shi C; Wang Y; Huang G J Exp Clin Cancer Res; 2020 Sep; 39(1):186. PubMed ID: 32928266 [TBL] [Abstract][Full Text] [Related]
9. Hsa_circ_0005320 affects cell proliferation and the cell cycle via the IGF2BP3/CDK2 axis in bladder cancer. Ji Q; Ma F; Zhang X; Liu Y; Wang P; Li M Cell Signal; 2024 Jul; 119():111154. PubMed ID: 38565412 [TBL] [Abstract][Full Text] [Related]
10. Exosomal circ_0007385 enhances non-small cell lung cancer cell proliferation and stemness via regulating miR-1253/FAM83A axis. Ning Z; Tian Y; Li Y; Zhao X; Zhang J; Wang C; Hu J; Shen H; Wu W Anticancer Drugs; 2022 Jan; 33(1):61-74. PubMed ID: 34620741 [TBL] [Abstract][Full Text] [Related]
11. Circular RNA_0001495 increases Robo1 expression by sponging microRNA-527 to promote the proliferation, migration and invasion of bladder cancer cells. Feng L; Fu D; Gao L; Cheng H; Zhu C; Zhang G Carcinogenesis; 2021 Aug; 42(8):1046-1055. PubMed ID: 34021307 [TBL] [Abstract][Full Text] [Related]
12. Circ_0008532 promotes bladder cancer progression by regulation of the miR-155-5p/miR-330-5p/MTGR1 axis. Chen L; Yang X; Zhao J; Xiong M; Almaraihah R; Chen Z; Hou T J Exp Clin Cancer Res; 2020 May; 39(1):94. PubMed ID: 32460831 [TBL] [Abstract][Full Text] [Related]
13. miR-665 expression predicts poor survival and promotes tumor metastasis by targeting NR4A3 in breast cancer. Zhao XG; Hu JY; Tang J; Yi W; Zhang MY; Deng R; Mai SJ; Weng NQ; Wang RQ; Liu J; Zhang HZ; He JH; Wang HY Cell Death Dis; 2019 Jun; 10(7):479. PubMed ID: 31209222 [TBL] [Abstract][Full Text] [Related]
14. Circular RNA circFLNA inhibits the development of bladder carcinoma through microRNA miR-216a-3p/BTG2 axis. Lin S; Wang L; Shi Z; Zhu A; Zhang G; Hong Z; Cheng C Bioengineered; 2021 Dec; 12(2):11376-11389. PubMed ID: 34852712 [TBL] [Abstract][Full Text] [Related]
15. Circular RNA hsa_circ_0068871 regulates FGFR3 expression and activates STAT3 by targeting miR-181a-5p to promote bladder cancer progression. Mao W; Huang X; Wang L; Zhang Z; Liu M; Li Y; Luo M; Yao X; Fan J; Geng J J Exp Clin Cancer Res; 2019 Apr; 38(1):169. PubMed ID: 30999937 [TBL] [Abstract][Full Text] [Related]
16. CircZNF609 promotes bladder cancer progression and inhibits cisplatin sensitivity via miR-1200/CDC25B pathway. Feng D; Lv J; Li K; Cao Q; Han J; Yu H; Cheng Y; Zhuang J; Cai L; Yang H; Yang X; Lu Q Cell Biol Toxicol; 2023 Oct; 39(5):1-18. PubMed ID: 35567596 [TBL] [Abstract][Full Text] [Related]
17. circSOBP Inhibits Bladder Cancer Proliferation and Metastasis by Regulating the miR-200a-3p/PTEN Axis and Participating in the Immune Response. Zhang Y; Li Z; Zhang Y; Shen C; Zhang Z; Ren X; Guo C; Yang S; Wang Z; Hu H Cell Transplant; 2023; 32():9636897231165874. PubMed ID: 37026617 [TBL] [Abstract][Full Text] [Related]
18. Circular RNA hsa_circ_0001785 inhibits the proliferation, migration and invasion of breast cancer cells in vitro and in vivo by sponging miR-942 to upregulate SOCS3. Li Z; Zheng J; Lin W; Weng J; Hong W; Zou J; Zhang T; Ye C; Chen Y Cell Cycle; 2020 Nov; 19(21):2811-2825. PubMed ID: 33054543 [TBL] [Abstract][Full Text] [Related]
19. Hsa_circ_0006677 regulates special AT-rich binding protein-2-mediated tumor-suppressive effect via functioning as a miR-1245a sponge in non-small cell lung cancer. Sui X; Liu Z; Niu L; Yin B; Huo C Bioengineered; 2022 Feb; 13(2):3760-3774. PubMed ID: 35081869 [TBL] [Abstract][Full Text] [Related]
20. Circular RNA circ-VANGL1 as a competing endogenous RNA contributes to bladder cancer progression by regulating miR-605-3p/VANGL1 pathway. Zeng Z; Zhou W; Duan L; Zhang J; Lu X; Jin L; Yu Y J Cell Physiol; 2019 Apr; 234(4):3887-3896. PubMed ID: 30146736 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]